A re-assessment of the role of combined androgen blockade for advanced prostate cancer.
Klotz
L
L
Sunnybrook & Women's College Health Sciences Centre, University of Toronto, Canada. Laurence.klotz@sw.ca
Schellhammer
P
P
Carroll
K
K
D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002369:Castration; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy / Q000379:methods; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D016896:Treatment Outcome
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal